|
n
|
140
|
20
| |
|
Age, mean ± SD
|
76.2 ± 11.08
|
73.3 ± 13.07
|
0.290
|
|
Male sex, n (%)
|
57 (40.7)
|
7(35.0)
|
0.626
|
|
Comorbidities and medication, n (%)
|
|
Hypertension
|
117 (83.6)
|
13 (65.0)
|
0.047
|
|
Diabetes mellitus
|
33 (23.6)
|
4 (20.0)
|
0.723
|
|
Hypercholesterolemia
|
42 (30.0)
|
4 (20.0)
|
0.355
|
|
Currently smoking
|
21 (15.0)
|
3 (15.0)
|
1.000
|
|
Previous stroke
|
28 (20.0)
|
4 (20.0)
|
1.000
|
|
Coronary artery disease
|
33 (23.6)
|
8 (40.0)
|
0.115
|
|
Peripheral artery disease
|
11 (7.9)
|
3 (15.0)
|
0.290
|
|
Atrial fibrillation
|
47 (33.6)
|
7 (35.0)
|
0.899
|
|
Need for dialysis
|
1 (0.7)
|
0 (0.0)
|
0.705
|
|
Antiplatelet therapy
|
52 (37.1)
|
6 (30.0)
|
0.534
|
|
Oral anticoagulants
|
22 (15.7)
|
5 (25.0)
|
0.300
|
|
Statin therapy
|
37 (26.4)
|
7 (35.0)
|
0.422
|
|
NIHSS on admission, mean ± SD
|
13.5 ± 7.06
|
16.6 ± 6.29
|
0.068
|
|
Premorbid mRS, n (%)
|
|
0–2
|
99 (70.7)
|
14 (70.0)
|
0.95
|
|
> 2
|
41 (29.3)
|
6 (30.0)
|
|
ASPECTS, mean ± SD a
|
8.2 ± 1.64
|
7.7 ± 2.06
|
0.149
|
|
Use of iv thrombolysis, n (%)
|
82 (58.6)
|
15 (75.0)
|
0.160
|
|
Site of occlusion, n (%)
|
|
Left sided occlusion
|
67 (48.2)
|
12 (60.0)
|
0.324
|
|
M1
|
61 (43.6)
|
10 (54.5)
|
0.591
|
|
M2
|
36 (25.7)
|
3 (13.6)
|
|
ICA
|
5 (3.6)
|
0 (0.0)
|
|
ICA + M1/2
|
37 (26.4)
|
7 (31.8)
|
|
P1
|
1 (0.6)
|
0
|
